Kenvue faces challenges with declining sales, cash flow risks, and high leverage. Read here for more analysis on KVUE stock.

Two years ago, when Johnson & Johnson announced it was spinning off its consumer brands including Tylenol, Band-Aid, Motrin, ...

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...

Kenvue Non-GAAP EPS of $1.29 beats by $1.01, revenue of $3.7B misses by $90M Kenvue gains as ruling in Tylenol case likely collapses plaintiffs case - analyst Recommended For You ...

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

Kenvue stock approaches a Golden Cross, signaling bullish momentum with the stock up 10% over the past month. Legal win over Tylenol gelcaps boosts Kenvue's momentum, as strong brand power fuels ...

Kenvue chief executive officer, Thibaut Mongon, has stepped down from the role and the company's board amid an ongoing ...

Why It Matters: Kenvue’s stock price has remained relatively unchanged this year, in contrast to the S&P 500 index’s 23% increase.The company’s biggest competitors include Haleon, the parent ...

Nestled among the overflowing buffet of Tylenol products at your local pharmacy is Tylenol 8 Hour — the extended-release ...

Kenvue's CEO and board member Thibaut Mongon has stepped down, it said on Monday, in the second big executive change at the ...